Jefferies Financial Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.39M | Buy |
170,570
+26,326
| +18% | +$832K | 0.05% | 193 |
|
|
2025
Q1 | $4.79M | Sell |
144,244
-161,356
| -53% | -$5.36M | 0.04% | 226 |
|
|
2024
Q4 | $10.5M | Buy |
305,600
+89,000
| +41% | +$3.06M | 0.06% | 147 |
|
|
2024
Q3 | $8.66M | Buy |
216,600
+166,100
| +329% | +$6.64M | 0.06% | 123 |
|
|
2024
Q2 | $1.52M | Buy |
50,500
+25,000
| +98% | +$754K | 0.02% | 456 |
|
|
2024
Q1 | $856K | Buy |
25,500
+4,800
| +23% | +$161K | 0.01% | 632 |
|
|
2023
Q4 | $669K | Buy |
+20,700
| New | +$669K | ﹤0.01% | 765 |
|
|
2023
Q3 | – | Sell |
-10,000
| Closed | -$352K | – | 1253 |
|
|
2023
Q2 | $352K | Buy |
+10,000
| New | +$352K | ﹤0.01% | 866 |
|